CSL Limited (ASX:CSL)
196.14
+0.06 (0.03%)
Oct 22, 2026, 4:18 PM AEDT
CSL Limited Revenue
In the fiscal year ending June 30, 2026, CSL Limited had annual revenue of $15.80B USD with 1.54% growth. CSL Limited had revenue of $7.47B in the half year ending June 30, 2026, with 10.64% growth. That makes CSL Limited the 958th largest company in the world by revenue and 12th in Australia.
Revenue
$15.80B
Revenue Growth
+1.54%
P/S Ratio
4.11
Revenue / Employee
$544.72K
Employees
29,000
Market Cap
93.93B AUD
Revenue by Segment
Fiscal year ended Jun 30, 2026 See the full CSL Limited breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 15.80B | 239.00M | 1.54% |
| Jun 30, 2025 | 15.56B | 758.00M | 5.12% |
| Jun 30, 2024 | 14.80B | 1.49B | 11.19% |
| Jun 30, 2023 | 13.31B | 2.75B | 26.02% |
| Jun 30, 2022 | 10.56B | 252.00M | 2.44% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Telix Pharmaceuticals | 1.29B |
| Mesoblast | 173.82M |
| Clinuvel Pharmaceuticals | 94.02M |
| BLS Pharmaceuticals | 73.91M |
| Neuren Pharmaceuticals | 69.53M |
| PYC Therapeutics | 25.99M |
| Starpharma Holdings | 12.67M |
| Orthocell | 11.41M |
CSL Limited News
- 1 day ago - CSL Appoints Deborah Waterhouse As CEO - Nasdaq
- 1 day ago - CSL appoints Deborah Waterhouse as CEO & Managing Director - PRNewsWire
- 1 day ago - Australia's CSL appoints Deborah Waterhouse as CEO - Reuters
- 17 days ago - CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases - PRNewsWire
- 23 days ago - Australia's CSL taps Amazon's cloud unit to boost research pipeline - Reuters
- 5 weeks ago - Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults - PRNewsWire
- 7 weeks ago - Trump Administration Reaches Drug Pricing Deals With 9 Companies - WSJ
- 7 weeks ago - Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers - CNBC